Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Recruiting 6 Not yet recruiting 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4 Breast 3 Tumor-Agnostic 2 Other hematologic neoplasm 2 Gynecologic 2 Gastrointestinal 2 CNS 2 Head & Neck 1 Endocrine 1

Conditions

Laryngeal Diseases 1

Interventions

Cisplatin 57 pembrolizumab 54 Cetuximab 43 Radiotherapy 35 Docetaxel 21 Radiotherapy, Intensity-Modulated 20 Paclitaxel 19 Nivolumab 18 Fluorouracil 18 Carboplatin 17 Radiation 14 Radiosurgery 9 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Everolimus 8 Biopsy 8 Surgical Procedures, Operative 7 Oxaliplatin 7 Cyclophosphamide 7 durvalumab 6 avelumab 6 Erlotinib Hydrochloride 6 Capecitabine 6 spartalizumab 5 epacadostat 5 Surveys and Questionnaires 5 Platinum 5 Immunoglobulin G 5 Gefitinib 5 Dexamethasone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interviews as Topic × Head & Neck × Clear all

NCT01647477 2026-03-13

DEREDIA

Centre Oscar Lambret

Phase NA Terminated

Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡